It was a weird political year, featuring a humiliating presidential election for the Government parties and a far happier ...
Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote. The Oncologic Drugs ...
The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by rejecting AstraZeneca’s PT010, a close competitor. AZ has confirmed that ...
This used to be the time of year when Old Trafford was buzzing with title talk. These days it's simply entitlement.
Britons say they have bought fewer Christmas presents this year because of the rising price of household goods. Some 51 per cent of people say they have cut back on the amount of gifts they have ...
Incentives are available to support the installation of green roofs and cool roofs on Toronto homes and buildings. Applications are accepted and reviewed on an on-going basis. Please apply before you ...
The Chancellor is rumuored to be considering a curb to the cash Isa of £12,000 instead of £10,000. The change comes after building societies raised concerns that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback